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XenopusAt the Xenopus midblastula transition (MBT), cell cycles lengthen, and checkpoints that respond to damaged
or unreplicated DNA are established. The MBT is triggered by a critical nucleocytoplasmic (N/C) ratio;
however, the molecular basis for its initiation remains unknown. In egg extracts, activation of Chk1
checkpoint kinase requires the adaptor protein Claspin, which recruits Chk1 for phosphorylation by ATR. At
the MBT in embryos, Chk1 is transiently activated to lengthen the cell cycle. We show that Xenopus Claspin is
phosphorylated at the MBT at both DNA replication checkpoint-dependent and -independent sites. Further, in
egg extracts, Claspin phosphorylation depends on a threshold N/C ratio, but occurs even when ATR is
inhibited. Not all phosphorylation that occurs at the MBT is reproduced in egg extracts. Our results identify
Claspin as the most upstream molecule in the signaling pathway that responds to the N/C ratio and indicate
that Claspin may also respond to an independent timer to trigger the MBT and activation of cell cycle
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Progression of early embryonic cell cycles is rapid in external
developers including Xenopus, Drosophila and zebraﬁsh (Edgar et al.,
1986; Kane and Kimmel, 1993; Newport and Kirschner, 1982a) and is
regulated by maternally supplied products. Thereafter, embryos begin
the MBT when cell cycles lengthen, transcription is activated, cells
become motile, and cell cycle checkpoints are established (Clute and
Masui, 1992, 1995; Dasso and Newport, 1990; Edgar et al., 1986; Kane
and Kimmel, 1993; Kappas et al., 2000; Newport and Dasso, 1989;
Newport and Kirschner, 1982a, 1982b).
Cell cycle checkpoints ensure the accurate transmission of genomic
information from a cell to its progeny (Elledge, 1996; Hartwell and
Weinert, 1989). The DNA replication checkpoint ismediated by sensors,
transducers, effectors and their targets (Zhou and Elledge, 2000). In
vertebrates, the protein kinase ATR transduces the signal from stalled
DNA replication complexes to effectors (Cimprich and Cortez, 2008),
including Chk1 kinase (Guo et al., 2000). Claspin, an adaptor protein,
recruits Chk1 for phosphorylation by ATR (Chini and Chen, 2003;
Kumagai and Dunphy, 2000, 2003). Phosphorylated, activated Chk1
phosphorylatesdownstreamtargets suchasCdc25 andWee1, leading tocell cycle delay or arrest prior to mitosis (Rhind and Russell, 2000).
The ATR-Chk1 pathway is required for normal progression of DNA
replication and cell survival even in the absence of exogenous inhibitors
of DNA replication (Petermann and Caldecott, 2006).
The prevailing explanation for the elongation of cell cycles at the
XenopusMBT is that as the N/C ratio increases during early embryonic
cell cycles, DNA content increases exponentially and titratesmaternally
supplied replication factors, resulting in stalled DNA replication forks.
These stalled forks activate a physiological checkpoint, inhibiting entry
into mitosis (Dasso and Newport, 1990; Newport and Dasso, 1989;
Newport and Kirschner, 1982a, 1982b; Shimuta et al., 2002).
In contrast, when DNA replication is blocked explicitly prior to the
MBT, embryonic cell cycles continue, and Chk1 is not activated (Kappas
et al., 2000). The titrationmodel correlates the timingofDNA replication
checkpoint activation with the MBT (Clute and Masui, 1992; Dasso and
Newport, 1990; Kappas et al., 2000;Newport andDasso, 1989), but does
not provide a molecular mechanism by which either is established.
Shimuta et al. (2002) showed that Chk1 is transiently activated at the
MBT via ATR. A role for Claspin has been established in the ATR-Chk1
pathway inegg extracts (Kumagai andDunphy, 2000, 2003), but Claspin
has not been investigated during the cell cycle remodeling period of
early embryogenesis. Here, we show that Xenopus Claspin is phosphor-
ylated via both ATR-dependent and ATR-independent mechanisms at
theMBT in embryos. Claspin phosphorylation depends on the N/C ratio
in egg extracts and occurs at sites induced by ATR in theDNA replication
checkpoint pathway. Additional phosphorylation events in embryos
may be regulated by the developmental timer that runs independently
of the N/C ratio (Ciliberto et al., 2003; Hartley et al., 1997; Howe and
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establishing DNA replication checkpoints at the MBT.
Materials and methods
Preparation of oocytes, embryos and cell-free egg extracts
Preparation of Xenopus oocytes and embryos and injections was
performed as described (Gotoh et al., 2001; Kappas et al., 2000). Some
embryos were incubated in the presence of 30 mM hydroxyurea
(Sigma) or 100 μg/ml aphidicolin (Wako and Calbiochem) and/or
5 mM caffeine (Sigma). Stock solutions were prepared as 1 M
hydroxyurea in distilledwater, 100 mMcaffeine in 10 mMPIPES-KOH,
pH 7.5, and 20 mg/ml aphidicolin in DMSO. Cytostatic factor (CSF)-
arrested extracts, nuclease-treated extracts and sperm nuclei were
prepared by the method of Murray (1991). To make interphase
extracts, the extracts were supplemented with 100 μg/ml cyclohexi-
mide (CHX) (Sigma) and released from CSF arrest with 0.4 mM CaCl2.
CHX was not added to the nuclease-treated extracts. Extracts were
then supplemented with the indicated concentration of sperm nuclei
or pBR322 plasmid.
Isolation of cDNA encoding Xenopus Claspin
cDNA fragments encoding N- or C-terminal half of Xenopus Claspin
protein were isolated by PCR using a Xenopus oocyte cDNA library and
Pyrobest DNA polymerase (Takara) with primers, 5′-CGCGGATC-
CATGGCCGCGCTTTGCGAAGAAG-3′ and 5′-GGAAGAATGCGGCCGCC-
TAATCATCCTCATCATTGTCATCTTCAG-3′ for its N-terminal half, and
5′-CGCGGATCCGGAAATGCTGAGACTGCAGATTATC-3′ and 5′-GGAA-Fig. 1. Claspin is phosphorylated at theMBT. (A) Temporal expressionof ClaspinmRNA.RT-PCR
Faber, 1956) using primers speciﬁc for Claspin and actin as a control. (B) Spatial expression o
indicated stages using anti-Claspin serum(a–e) andpreimmune serumas a control (f). AnandV
animal pole. (C) Temporal expression of Claspin protein. Western blotting with anti-Claspin, a
extracts frommature oocytes and staged embryos (ﬁrst row), or in amore detailed time course
fertilization (second through ﬁfth rows). Proteins equivalent to those from half an embryowere
Someembryoswere treatedwithhydroxyurea (HU) fromthe2–4-cell stage andwere collected
anti-Claspin antiserum. Immunoprecipitates were treated without (−) or with (+) lambda
subjected to Western blotting with an anti-Claspin antibody. -=unphosphorylated Claspin, anGAATGCGGCCGCCTACTCCAACAACTGAAATATACTGC-3′ for its C-terminal
half. A 1.9 kbp BamHI-NotI fragment encoding the N-terminal half of the
protein (amino acids 1–654) (this N-terminal half has one more amino
acid than the Claspin protein described in Kumagai and Dunphy, 2000)
and a 1.9 kbp BamHI-NotI fragment encoding the C-terminal half of the
protein (amino acids 626–1286) were cloned into pBluescriptII SK(−).
These vectors containing the cDNA of N- or C-terminal half of Claspin
protein were designated as pBSII-Claspin-Nt or pBSII-Claspin-Ct, respec-
tively. To obtain full-length Claspin cDNA, a 1.6 kbp XhoI-NotI fragment
frompBSII-Claspin-Ctwascloned intopGEX-4T-3 (GEHealthcare) toyield
pGEX-Claspin-C (amino acids 745–1286). A 2.2 kbp BamHI-XhoI frag-
ment encoding the N-terminal half of the protein (amino acids 1–744)
was combined by PCR using pBSII-Claspin-Nt and pBSII-Claspin-Ct with
four primers, 5′-GGGGATCCATGGCCGCGCTTTGCG-3′, 5′-CAACTC-
GAGTTGTTTTATTACATGGC-3′, 5′-CATCCTCATCATTGTCATCTTCAGCAT-
CAC-3′, and 5′-GGAAATGCTGAGACTGCAGATTATCCTGG-3′ was cloned
into pGEX-Claspin-C that was digested with BamHI and XhoI to yield a
vector encoding full-length Claspin (GeneBank accession no. AB526250).
DNA sequencing of Claspin cDNA was performed.
DNA constructions
Toobtain pTrcHis2A-Claspin (1–472), pBSII-Claspin-Ntwasdigested
with BamHI and HindIII. The BamHI-HindIII fragment was cloned into
pTrcHis2A (Invitrogen) that was digested with BglII and HindIII.
To obtain pRNT3-3xFLAG-XClaspin-Nt or -Ct, pRNT3-3xFLAG vector
was created by inserting two annealed oligonucleotides encoding a
triple FLAG tag with the restriction enzyme sites (BglII and NotI) into
pRNT3 (Gotoh et al., 2001). pBSII-Claspin-Nt or -Ct was digested with
BamHI and NotI, and the BamHI-NotI fragments were cloned intowasperformedonRNA isolated frommatureoocytes and stagedembryos (Nieuwkoop and
f Claspin protein. Whole-mount immunohistochemistry was performed with embryos at
eg denote a view fromanimal and vegetal poles, respectively. Unlabeled views are fromthe
nti-phospho Chk1, anti-Cdk1 or anti-phospho Cdk1 (Y15) antibodies was performed on
, from early blastula (stage 7) to early gastrula (stage 10) embryos at indicated times after
analyzed. (D) Fertilized eggs (stage 1) and late blastula embryos (stage 9)were collected.
at the late blastula stage. The embryoextractswere subject to immunoprecipitationwith an
phosphatase. Embryo extracts (left panel) and immunoprecipitates (right panel) were
d P=phosphorylated Claspin.
Fig. 2. At the MBT, Claspin is phosphorylated both independently and dependently of the
ATR pathway. (A) Embryos were treatedwithout (−) or with aphidicolin (APH) from the
mid-(stage 8) to the late-(stage 9) blastula stage in the absence (−) or presence (+) of
caffeine. Extracts from untreated pre-MBT (stage 8) embryos are shown for comparison.
(B) Morula (stage 6.5), late blastula (stage 9) or HU-treated embryos were collected in
Fig. 1D. Embryo extracts were subjected toWestern blotting using anti-Claspin, anti-Chk1
and anti-phospho Claspin (S865) antibodies. In (B), anti-Claspin antibody was used after
stripping off anti-phospho-Claspin (S865) antibody.
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in which T818, S820, S865, S896, T907 and/or S935 were substituted
with alanine were made using PCR-based mutagenesis.Semi-quantitative RT-PCR
Total RNA was extracted from oocytes and embryos using Trizol
reagent (Invitrogen) and treated with RNase-free DNase I (Ambion).
cDNAwas synthesized from the extracted RNAusing oligo(dT)15 primer
(Promega) andMMLV reverse transcriptase (Fisher Scientiﬁc). Aliquots
of the reaction products were subjected to PCR (95 °C for 30 s, 55 °C for
30 s, and 72 °C for 1 min) for 25 cycles; the forward and reverse PCR
primers were respectively, 5′-GCTGCGCGACTTGGTAAAGAAGCC-3′ and
5′-CATCCTCATCATTGTCATCTTCAGCATCAC-3′ for Claspin, and 5′-GAA
GCCCAAAGCAAGAGAGGTATCC-3′ and 5′-ATCTGCTGGAAAGTGGA-
GAGTGAGG-3′ for Xenopus β-actin type 8 as control. The reaction
products were fractionated on agarose gels and stained.Fig. 3. Claspin is phosphorylated at the MBT at previously identiﬁed and novel residues. (A) S
3xFLAG tag. Phosphorylation sites were mutated in the 4SA2TA construction as shown. RFID, C
and Chk1-binding domain, respectively (Kumagai and Dunphy, 2003; Lee et al., 2005). (B and C
-Ct, cultured, and collected at the indicated hours post-fertilization (hpf) (B). TheMBT occurred
using anti-FLAG antibodies, followedby treatmentwith (+)orwithout (−) lambdaphosphatas
FLAG antibodies. (D) Fertilized eggswere injectedwithmRNA encoding either Claspin-Nt, Clasp
aphidicolin (APH) frommid-blastula stage (stage 8; 6.5 hpf) to late blastula stage (stage 9; 8.5 h
antibodies. P1, P2, and U denote phosphorylation dependent on physiological checkpoint (Sh
unphosphorylated Claspin, respectively.Production of anti-Xenopus Claspin antibodies
pTrcHis2A-Claspin (1–472) construction was introduced into E. coli
BL21. Claspin (1–472)-His6/Myc was used for immunization of rabbits.
Another Claspin antiserum was raised in rabbits against a synthetic
peptide of the C terminus of Claspin ([C]STPTVKSRSIFQLLE; ﬁrst C is
added for coupling with KLH). Whole serum was afﬁnity-puriﬁed
against the peptide antigen coupled to Sulfolink agarose beads (Pierce).
See supplementary Fig. S1 for characterization of antibodies.
Immunoprecipitation
Embryonic extracts for immunoprecipitation were made as de-
scribed (Gotoh et al., 2001; Kappas et al., 2000). Extractswere incubated
with 20 μl of protein A-Sepharose 4B (Sigma) and 2 μg of control rabbit
IgG (Zymed) for 30 min at 4 °C with constant rotation. After removal of
the beads by centrifugation, 20 μl of protein A-Sepharose 4B and
appropriate antisera or puriﬁed antibodies were added to the
supernatant. After a two-hour incubation with constant rotation at
4 °C, the beads were washed four times with bead wash buffer (5 mM
NaF, 250 mMNaCl, 5 mMEGTA, 5 mMEDTA, 0.5 mMPMSF, 0.1%NP-40,
50 mM Tris–HCl, pH 7.5). The immunoprecipitates were dissolved in
SDS-sample buffer, and boiled for 3 min, followed by separation with
SDS-PAGE. In some experiments, the immunoprecipitates were treated
with 1000 U lambda phosphatase (New England Biolabs) for 30 min at
25 °C after washing with lambda phosphatase buffer. The immunopre-
cipitates were dissolved in SDS-sample buffer, followed by separation
with SDS-PAGE.
Western blotting
Western blot analysis was performed as described (Gotoh et al., 2001;
Kappas et al., 2000). The primary antibodies used in this study were
anti-Xenopus Claspin, anti-Xenopus Chk1 (a gift from Drs. Sagata and
Nakajo, Kyushu University), anti-phospho Xenopus Claspin (S865) (a gift
from Drs. Dunphy and Kumagai, California Institute of Technology), anti-chematic of N-terminal (Nt) or C-terminal (Ct) fragments of Claspin with an N-terminal
KAD and CKBD denote replication fork-interacting domain, small Chk1-activating domain
) One and two-cell stage embryos were injectedwithmRNA encoding either Claspin-Nt or
at 7 hpf. Immunoprecipitationwas performed on embryos collected at 9 hpf (late blastula)
e (C). Embryos and the immunoprecipitateswere subjected toWestern blotting using anti-
in-Ct or the 4SA2TAmutant, and cultured. Embryoswere treatedwithout (−) orwith (+)
pf), and collected. The embryo extractswere subjected toWestern blottingusing anti-FLAG
imuta et al., 2002)/DNA replication checkpoint, phosphorylation speciﬁc to the MBT, and
Fig. 4. Claspin phosphorylation is dependent on nucleocytoplasmic ratio in egg extracts. (A and B) The indicated concentration of nuclei or pBR322 plasmid was added to interphase
egg extracts without (−) or with (+) caffeine, an ATR inhibitor (B). Extracts were incubated at room temperature, and collected at 90 min after addition of nuclei or plasmid.
(C) Nuclease-treated interphase extracts were supplemented with 3xFLAG-Claspin-Ct mRNA (WT) or the indicated Ctmutants without (−) or with (+) caffeine. After incubation for
30 min, the extracts were supplemented with 5000 nuclei/μl, incubated for 70 min, and collected. The extracts were subjected toWestern blotting using anti-Claspin, anti-FLAG and
anti-phospho human Chk1 (S345) antibodies.
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(Cell Signaling), anti-phospho human Chk1 (S345) (Cell Signaling), and
anti-FLAG (Sigma) antibodies. The secondary antibodies were alkaline
phosphatase- (DAKO) or horseradish peroxidase-conjugated anti-rabbit
IgG antibody (Cell Signaling), or horseradish peroxidase-conjugated anti-
mouse IgGantibody(Jackson Immunoreseach). Signalswerevisualizedby
BCIP/NBT phosphatase substrate system (KPL), the ECL plus system
(GE Healthcare) or the Supersignal West Fempto maximum sensitivity
substrate (Pierce).
Immunohistochemistry
Whole-mount immunohistochemistry for Claspinwas performed as
previously described (Sive et al., 2000) using embryos ﬁxed in MEMFA
buffer (2 mM EGTA, 1 mMMgSO4, 3.7% formaldehyde, 0.1 MMOPS, pH
7.4) and detectedwith anHRP-conjugated secondary antibody (Jackson
immunoresearch) using diaminobenzidine (DAB) as substrates.
Results and discussion
Claspin is phosphorylated at the MBT
We ﬁrst investigated the developmental expression pattern of
Claspinduring embryogenesis. ClaspinmRNAwaspresent at a relatively
constant level until the late blastula stage and decreased following
gastrulation, but remained detectable at the tadpole stage (Fig. 1A).
Whole-mount immunohistochemistry showed that Claspin proteinwas
distributed in bothnuclei and cytoplasm at the early blastula stage, then
concentrated in nuclei after theMBT (Fig. 1B).Western analysis showed
that Claspin protein level was constant until the blastula stage. Claspin
was modiﬁed at the MBT (Fig. 1C), coinciding with inhibitory
phosphorylation of Cdk1, an indicator of cell cycle elongation, and
activating Chk1 phosphorylation on S343. Claspin modiﬁcation was not
observed during oogenesis and oocyte maturation (data not shown),
indicating that it is speciﬁc to the MBT.
Phosphatase treatment of immunoprecipitated Claspin abolished
the mobility shift in late blastula embryos (St. 9) and embryos in which
the DNA-replication checkpoint was activated by hydroxyurea (HU)
(Fig. 1D), indicating that the modiﬁcation is phosphorylation. Phospha-tase treatment also generated a faster migrating Claspin in fertilized
eggs (St. 1; Fig. 1D), suggesting that Claspin is constitutively
phosphorylated pre-MBT, then becomes further phosphorylated at the
MBT.
Claspin becomes phosphorylated at the MBT both independently and
dependently of ATR signaling
When DNA replication is blocked in egg extracts, Claspin is
phosphorylated on S865 and S896 dependently on ATR (Kumagai and
Dunphy, 2003). To investigate whether Claspin phosphorylation at the
MBToccurs via the same pathway,we treated embryoswith caffeine, an
ATR inhibitor, in the presence or absence of the DNA replication
inhibitors, aphidicolin. When embryos were treated with aphidicolin
from the early to late blastula stages, Claspin and Chk1 were
phosphorylated (mobility shift on SDS-PAGE), and the shift of Chk1
was completely inhibited by treatment with caffeine, suggesting that
phosphorylation of Chk1 in response to unreplicated DNA in embryos
depends on ATR as in egg extracts (Kumagai and Dunphy, 2003).
However, the shift of Claspinwas not completely inhibited by treatment
with caffeine (Fig. 2A), suggesting that only a portion of this Claspin
phosphorylation depends on ATR. In contrast, the phosphorylation of
Claspin after the MBT that occurs in the absence of DNA replication
inhibitors was not blocked by caffeine (Fig. 2A; compare pre-MBT Stage
8 to post-MBT (remaining lanes)), suggesting that during normal
development, Claspin is phosphorylated independentof ATRat theMBT.
This result contrasts with the phosphorylation of Chk1 at the MBT,
which is blocked completely by caffeine (Shimuta et al., 2002). For a
more speciﬁc assay, we performed Western blotting using an antibody
speciﬁc to Claspin phosphorylated on S865, a site reported to depend on
ATR in egg extracts (Kumagai and Dunphy, 2003). We found that S865
became phosphorylated after the MBT but at a much lower level than
what occurs when the DNA replication checkpoint was activated with
HU (Fig. 2B). Together, these results suggest that Claspin phosphorylation
at the MBT includes events both dependent and independent of the
ATR-mediated pathway.
To determine which region of Claspin was phosphorylated, we
injected mRNAs encoding N-terminal (Nt: 1–654) or C-terminal
(Ct: 626–1286) fragments of Claspin with a 3xFLAG tag (Fig. 3A) into
Fig. 5. Model for the regulation of cell cycle elongation through Claspin at the Xenopus MBT. Because of the exponentially increased nucleocytoplasmic (N/C) ratio, maternal DNA
replication factors become titrated. The consequently stalled DNA replication forks activate ATR through sensors (caffeine-sensitive pathway; orange arrows). Coincidently, maternal
factor(s) that inhibit kinase activity become titrated by DNA, and Claspin is phosphorylated (caffeine-insensitive and N/C ratio-dependent pathway; red arrows). This kinase activity
and ATR consequently induce phosphorylation of Claspin on S865, S896, and T907 (black circles), stimulating Chk1 phosphorylation by ATR to activate Chk1, and leading to
elongation of the cell cycle. We hypothesize that at the MBT, Claspin is also phosphorylated at additional sites (gray pathway), an event that is timed independently of the N/C ratio.
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blotting. The Nt fragment, which contains the replication fork
interacting domain, was not modiﬁed during the experiment,
whereas the Ct fragment, which contains the Chk1-activating and
Chk1-binding domains, was modiﬁed after the MBT (Fig. 3B).
Phosphatase treatment abolished the mobility shift of Ct in post-
MBT embryos (Fig. 3C), indicating that the modiﬁcation is phosphor-
ylation. The Nt fragment also shifted to a faster mobility after
phosphatase treatment (Fig. 3C), indicating that Nt was constitutively
phosphorylated. Next, we determined whether Ct was phosphorylat-
ed on sites reported previously as needed for DNA replication/damage
checkpoints or adaptation (Fig. 3D; (Kumagai and Dunphy, 2003; Yoo
et al., 2006, 2004)). We injectedmRNA encoding the Ct fragment with
those phosphorylation sites mutated to alanine (4SA2TA) into
fertilized eggs. The wild-type Ct fragment had a mobility shift (P2)
not observed in the 4SA2TA mutant in unperturbed cell cycles or
during activation of the DNA replication checkpoint (Fig. 3D).
However, the 4SA2TA mutant possessed the major phosphorylation
band (P1) at the MBT (Fig. 3D). These results suggest that phosphor-
ylation of Claspin at the MBT occurs at both the same and distinct sites
from those identiﬁed in studies of checkpoints or adaptation in egg
extracts.Claspin phosphorylation depends on the N/C ratio
ToexaminewhetherClaspinphosphorylation isdependent on theN/
C ratio like many events of the MBT, we prepared interphase egg
extracts supplementedwith spermnuclei.When nuclei were added at a
concentration of 2000/μl or higher, which approximates nuclear
concentration at the MBT (Conn et al., 2004), Claspin was phosphor-
ylated (Fig. 4A, top). To examine if DNA alone induces phosphorylation
of Claspin, we added plasmids to extracts. When plasmid equivalent to
more than 2000 nuclei (6.36 ng)/μl was added, Claspin was phosphor-
ylated (Fig. 4A, bottom), suggesting that a critical amount of DNA, rather
than thenumber of nuclei, inducesClaspinphosphorylation. Toexamine
if Claspin phosphorylation depends on ATR, we added caffeine before
addition of sperm nuclei. Western blotting showed that the Claspin
phosphorylation induced by higher concentrations of DNA was
insensitive to caffeine (Fig. 4B). The phosphorylation patterns of Claspin
on SDS-PAGE were similar to those in embryos at the MBT (supple-
mentary Fig. S2A). In contrast, the phosphorylation of Chk1 that was
induced at higher concentrations of nuclei was completely abolished by
caffeine (Fig. 4B). Thus, eggs possess an inherent, ATR-independent
system that phosphorylates Claspin in response to a critical amount of
DNA.
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we addedwild-type (WT) andmutants (M1–M5) of 3xFLAG-Claspin-Ct
mRNA to nuclease-treated interphase extracts and then supplemented
with sperm nuclei. Western blotting showed that Ct phosphorylation
was insensitive to caffeine (Fig. 4C) and dependent on nuclear
concentration (supplementary Fig. S2B), and that mutation of S865,
S896 and T907 to alanine in the Ct fragment abolished phosphorylation
(Fig. 4C; mutant M3), indicating that the phosphorylation depends on
these residues. Interestingly, it has been reported previously that these
phosphorylation sites are dependent on ATR (Kumagai and Dunphy,
2003; Yoo et al., 2004). In nuclease-treated extracts, the 4SA2TAmutant
of Ct (M5) did not have the phosphorylation patterns that this mutant
displayed in post-MBT embryos (compare Fig. 3D with Fig. 4C). These
results suggest that a critical N/C ratio leads to Claspin phosphorylation
on S865, S896 and T907, independently of ATR, and that Claspin may
also haveMBT-speciﬁc phosphorylation that is triggered independently
of the N/C ratio.
Additional data showed that in egg extracts, in contrast to
endogenous Claspin and Chk1, neither the Ct nor the 4SA2TA mutant
showed additional modiﬁcations in response to aphidicolin at higher
concentrations of nuclei (Supplementary Fig. S2).A model for Claspin activation at the MBT
During early Xenopus development, DNA replication checkpoint
control is established at the MBT (Dasso and Newport, 1990; Kappas
et al., 2000; Newport and Dasso, 1989) when Chk1 becomes
phosphorylated and activated via ATR (Shimuta et al., 2002). Conn
et al. (2004) showed that exogenous DNA approximating the N/C ratio
at the MBT was sufﬁcient to activate Chk1 in pre-MBT embryos in an
ATR-dependent manner. Here, we show that Claspin becomes phos-
phorylated at the MBT and is sensitive to the N/C but that much of its
phosphorylation is ATR-independent (caffeine-insensitive). In support
of a critical role for Claspin at this stage of embryonic development,
expression of a catalytically inactive N-terminal fragment of Chk1
(Chk1-Nt-NA), that can bind Claspin as a dominant-negative inhibitor
(Jeong et al., 2003), resulted in embryonic death after the MBT
(Supplementary Fig. S3), consistent with the report that inhibition of
Chk1 leads to embryonic death (Shimuta et al., 2002). The T153A
mutant,whichdoes not bind toClaspin (Jeonget al., 2003), had no effect
on development. Fitting our data with that from previous studies, we
propose a mechanism whereby Claspin phosphorylation helps to
establish the DNA replication checkpoint at the MBT through multiple
signaling inputs (Fig. 5).
Increasing the N/C ratio triggers two independent events: (1)
Maternal replication factors are titrated and DNA replication slows.
Stalled DNA replication forks activate ATR kinase (Dasso and Newport,
1990; Newport andDasso, 1989;Newport and Kirschner, 1982a, 1982b;
Shimuta et al., 2002). (2) DNA also titrates a kinase inhibitor
(or activates a kinase directly), reinforcing phosphorylation of Claspin
by ATR and creating a stable pool of functional, phosphorylated Claspin,
which then binds to and promotes activation of Chk1, leading to cell
cycle lengthening. The latter event is consistent with the data of Conn
et al. (2004) and prediction of Pogoriler and Du (2004) that Chk1
activation may be regulated in part by the N/C ratio and not solely by
unreplicated or damaged DNA.
Our data suggest an additional branch of this pathway, albeit a more
speculative one at this stage. Claspin is also phosphorylated, likely at
distinct sites, at the MBT but these phosphorylation events are not
reproduced in cell-free extracts supplemented with an MBT-concen-
tration of DNA or nuclei. This result adds to the accumulating body of
data describing N/C independent timer that drives events of the MBT
includingdegradation ofmaternal cyclin E (Ciliberto et al., 2003;Hartley
et al., 1996; Howe and Newport, 1996). Continued investigation of this
timer and its role in cell cycle remodeling at the MBT is needed.In conclusion, we have shown that Claspin is phosphorylated
independently of DNA replication checkpoint but dependently on a
threshold N/C ratio at phosphorylation sites induced by ATR. This study
identiﬁes Claspin as the most upstream factor in the DNA replication
checkpoint pathway to respond to a threshold N/C ratio, and suggests
that Claspin phosphorylation may be an independent trigger point to
initiate cell cycle remodeling events at the MBT.
Supplementarymaterials related to this article canbe foundonlineat
doi:10.1016/j.ydbio.2011.03.002.Acknowledgments
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